INEOS Inovyn agrees to acquire the UK's only Ethylene dichloride asset from administration.

<p><strong>&nbsp;</strong></p> <ul> <li>The transaction also includes the remaining 50% of shares of Runcorn MCP Limited owned by Vynova Runcorn Limited.</li> <li>Strengthens the continuity of strategically critical chlor‑alkali operations in the UK, underpinning water treatment, chemicals production and food manufacturing.</li> <li>Stephen Dossett, CEO of INEOS Inovyn, said: <strong>&ldquo;This agreement reflects our confidence in the long-term future of the Runcorn site and its skilled workforce. Chlor-alkali products are essential to modern life, supporting safe drinking water, pharmaceutical and healthcare, and the materials that underpin housing and critical infrastructure. This acquisition is an important step in strengthening the UK's national resilience.&rdquo;</strong></li> <li>The transaction is subject to regulatory approvals and is expected to complete later this year.</li> </ul> <hr /> <p>INEOS Inovyn has today confirmed that it has agreed to acquire the remaining 50% shareholding in Runcorn MCP Limited, together with the assets and employees associated with EDC production at Runcorn from Vynova Runcorn Limited, following its entry into administration in 2025. The acquisition remains subject to the completion of the necessary legal and regulatory processes.</p> <p>The transaction is expected to complete later this year and will fully integrate the chlor-alkali and EDC value chain under INEOS Inovyn. By bringing these businesses together, INEOS Inovyn will strengthen the long-term future of the site and enhance security of supply for customers.</p> <p>Around 98% of the chlorine used in drinking water treatment is supplied by Runcorn, highlighting the site&rsquo;s critical importance to public health and national infrastructure.</p> <p>The acquisition represents an important step in safeguarding the continuity of strategically critical chlor-alkali operations in the UK. These products are essential for water treatment and food manufacturing and support a wide range of industries, including pharmaceuticals, healthcare and construction. Strengthening the UK's chlor-alkali backbone is vital for strategic autonomy and national resilience.</p> <p><strong>ENDS</strong></p> <h4>Media Contacts</h4> <p>INEOS PR &nbsp;| &nbsp;+44 (0) 207 193 9030 |&nbsp;<a href="mailto:ineos@firstlightgroup.io">ineos@firstlightgroup.io</a></p> <p><span style="letter-spacing: -0.256px;">Paul Tuohy | INEOS Inovyn&nbsp;</span><span style="letter-spacing: -0.256px;"> +44 (0) 7766 990756 |&nbsp;</span><span style="letter-spacing: -0.256px; font-size: 1rem;">Paul.Tuohy@ineos.com&nbsp;</span></p> <p>Richard Longden | INEOS | +41 79 962 61 23 |&nbsp;<a href="mailto:richard.longden@ineos.com">richard.longden@ineos.com</a></p> <h4>Note to Editors</h4> <p><strong>About INEOS Inovyn</strong></p> <p>INEOS Inovyn is Europe's largest producer of chlorvinyls and the global leader in speciality PVC. We deliver products that are essential for modern life, from construction and automotive, to healthcare and renewable energy. Our business is committed to play a key role in the Net Zero transition, through offering low greenhouse gas products and developing new technologies for recycling PVC</p> <p>With annual sales of &euro;3 billion, INEOS Inovyn employs circa 4,000 people and has manufacturing, sales and marketing operations in 8 countries across Europe. Our portfolio consists of an extensive range of best-in-class products arranged across General Purpose Vinyls, Specialty Vinyls, Organic Chlorine Derivatives, Chlor-Alkali, Hydrogen and Performance Chemicals.&nbsp; INEOS Inovyn's annual commercial production volume is approximately 9 million tonnes.</p> <p><strong>ABOUT INEOS<br /></strong></p> <p>INEOS products are essential in the modern world.&nbsp;Incredibly versatile, petrochemicals are used in a wide range of end-market applications to save lives, improve health and enhance standards of living. INEOS Group is a global manufacturer of petrochemicals, speciality chemicals and oil products. Our scope of operations has diversified with the launch of INEOS Automotive and the acquisition of our professional sports portfolio including football, cycling, and Formula1.&nbsp;INEOS comprises of&nbsp;28 individual businesses,&nbsp;we operate 148&nbsp;facilities in 26 countries around the world employing around 23,000 people. <br /><br /><br />&nbsp;</p>

Publication

INEOS latest news RSS · Commodity/Energy Organisation

Published

21st August 2026

Original report

ineos.com

ProcIntel stores what the source published in its feed — a headline, a summary and a link. It does not store or reproduce the full article.